Case Control Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1259-1270
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1259
Table 3 Uni-variate analysis after propensity score matching
Factors
IFD (n = 97)
Non-IFD (n = 194)
χ²
OR (95%CI)
P value
Age (< 65/≥ 65 yr)57/40110/840.1121.09 (0.66-1.78)0.737
BMI (< 24/≥ 24 kg/m2)51/46105/890.0620.94 (0.58-1.53)0.803
The systom of obstruction (No/Yes)70/27153/411.6220.69 (0.40-1.22)0.203
Total colonscopy (No/Yes)43/5473/1211.2111.32 (0.80-2.16)0.271
The CFR occupation (≥ 1/2/< 1/2)63/34131/630.1930.89 (0.53-1.49)0.660
Neoadjuvant therapy (No/Yes)91/6181/110.0310.91 (0.33-2.54)0.860
Colonscopy pre-surgery (No/Yes)71/26151/430.7690.78 (0.44-1.37)0.380
Re-location pre-surgery (No/Yes)76/21166/282.4050.61 (0.33-1.14)0.121
Polypectomy pre-surgery (No/Yes) 83/14172/220.5710.76 (0.37-1.56)0.450
Obstruction pre-surgery (No/Yes)83/14185/98.5210.29 (0.12-0.69)0.004
PGEP (1-2/3 packages)63/34139/551.3681.36 (0.81-2.30)0.243
Cephingosporins pre-surgery (No/Yes)87/10159/352.9571.92 (0.90-4.05)0.085
Metronidazole pre-surgery (No/Yes)49/48134/609.5410.46 (0.28-0.75)0.002
Operation duration (≥ 130/< 130 min)48/49102/920.2480.88 (0.54-1.44)0.619
Total blood loss (≥ 20/< 20 mL)66/31138/560.2950.86 (0.51-1.46)0.587
Stoma (No/Yes)93/4192/21.7230.24 (0.04-1.35)0.189
Antibotics post-surgery (No/Yes)79/18187/718.4010.16 (0.07-0.41)< 0.001
Nutrition supply pre-surgery, n (%)33.880< 0.001
    EN42 (43.3)37 (19.1)1 (Refrence)
    PN17 (17.5)99 (51.0)6.61(3.35-13.03)
    GNS38 (39.2)58 (29.9)1.73 (0.95-3.16)